Has Gorav Ailawadi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $434,258 in general payments to Gorav Ailawadi, MD across 671 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Gorav Ailawadi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Gorav Ailawadi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Gorav Ailawadi, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Ann Arbor, MINPI 1710196894

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (52.7%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Edwards Lifesciences at 27.7% of the total. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$434,258in general payments, 2019–2025

Across 671 payments — averaging $647.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Edwards Lifesciences$120K
Medtronic$91K
Arthrex$83K
Philips North America LLC$44K
Abbott$37K
W. L. Gore & Associates, Inc.$34K
plus $24K from 17 others

$992,965in research payments, 2019–2025

Across 111 payments — averaging $8945.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Edwards Lifesciences$594K
AbbVie$167K
Vascular Graft Solutions Inc$106K
Abbott$97K
Atricure, Inc.$23K
Medtronic$6K

What the payments were for

Consulting fees$228,88353%
Speaking & faculty fees$87,28120%
Grants$5000%
Travel & lodging$93,83522%
Food & beverage$23,7595%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Edwards Lifesciences	188	$120,274
Medtronic(2 entities)	181	$91,264
Arthrex	76	$83,043
Philips North America LLC	47	$43,587
Abbott	105	$37,223
W. L. Gore & Associates, Inc.	31	$34,443
Admedus Corporation	2	$12,000
Jenavalve Technology, Inc.	5	$4,463
Artivion, Inc.	2	$2,128
Corcym Inc	5	$1,843
Ancora Heart, Inc.	2	$1,222
Johnson & Johnson	4	$967
Livanova USA, Inc.	3	$418
Atricure, Inc.	3	$289
Pinnacle, Inc	5	$257
Enablecv Inc.	1	$202
Bolton Medical Inc	2	$184
Baxter Healthcare	4	$132
Medistim USA, Inc.	1	$105
Osprey Medical Inc	1	$89
Kestra Medical Technology Services, Inc.	1	$80
Tricoast Surgical Solutions LLC	1	$27
Hemosonics LLC	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Avalus$48,204
(9520) IGT Devices Undivided$42,942
Product in Development$34,018
Mitra Clip system$14,658
Simulus$13,007
Edwards SAPIEN 3 Transcatheter Heart Valve$12,115
ARTHREX$8,399
MitraClip System$7,034
CG Future$6,229
JenaValve Pericardial TAVR System$4,178
Penditure$3,808
Perceval$2,136
ON-X AORTIC HEART VALVE WITH CONFORM-X SEWING RING AND EXTENDED HOLDER$2,128
Epic$1,977
TENDYNE$1,800
MitraClip$1,150
INSPIRIS RESILIA aortic valve$900
Mosaic$866
PROLENE$758
TRIFECTA$750

How this compares

$434,258 in reported general payments places this provider in the 95th percentile of 182 thoracic surgery (cardiothoracic vascular surgery) providers in Michigan.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Michigan →

Medicare billing

Part B allowed, 2024

$123,688

Medicare patients

105

Services billed

202

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Potassium Chloride	27	$309
Furosemide	17	$78

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Ann Arbor

Steven BollingAnn Arbor$41.7M
Shinichi FukuharaAnn Arbor$236K
Bo YangAnn Arbor$180K
Matthew RomanoAnn Arbor$177K
Chigozirim EkekeAnn Arbor$92K
Himanshu PatelAnn Arbor$58K
Rishindra ReddyAnn Arbor$58K
Barbara HamiltonAnn Arbor$34K
Kenneth HasslerAnn Arbor$31K
Tessa WattAnn Arbor$22K

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →